Adrenal morpho-functional alterations in patients with acromegaly

Journal of Endocrinological Investigation

Volumn 31, Issue 7, 2008, Pages 602-606

  Scaroni, Carla ^a   Selice, R ^a   Benedini, S ^a   De Menis, E ^b   Arosio, M ^c,d   Ronchi, C ^d   Gasperi, M ^e   Manetti, L ^f   Arnaldi, G ^g   Polenta, B ^g   Boscaro, M ^g   Albiger, N ^a   Martino, E ^f   Mantero, F ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b OSPEDALE CA FONCELLO   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^e UNIVERSITY OF MOLISE   (Italy)

^f UNIVERSITY OF PISA   (Italy)

^g UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Acromegaly; Adrenal mass; Cushing's syndrome

Indexed keywords

ADRENALIN; CORTICOTROPIN; GROWTH HORMONE; HYDROCORTISONE; METADRENALIN; NORADRENALIN; NORMETADRENALIN; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE;

ACROMEGALY; ADRENAL CORTEX ADENOMA; ADRENAL HYPERPLASIA; ADRENALIN URINE LEVEL; ADULT; ARTICLE; BENIGN TUMOR; CATECHOLAMINE URINE LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MYELOLIPOMA; NEUROSURGERY; NORADRENALIN URINE LEVEL; PLASMA RENIN ACTIVITY; PREVALENCE; TUMOR VOLUME; URINALYSIS; URINARY FREE CORTISOL;

EID: 54949113924     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345609     Document Type: Article

References (42)

1. Holdaway IM, Rajasoorya RC, Gamble GD. Factors influencing mortality in acromegaly. J Clin Endocrinol Metab 2004, 89: 667-74.
2. Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 2000, 21: 215-44.
3. Ezzat S, Melmed S. Clinical review 18: Are patients with acromegaly at increased risk for neoplasia? J Clin Endocrinol Metab 1991, 72: 245-9.
4. Tita P, Ambrosio MR, Scollo C, et al. High prevalence of differentiated thyroid carcinoma in acromegaly. Clin Endocrinol (Oxf) 2005, 63: 161-7.
5. Gasperi M, Martino E, Manetti L, et al; Acromegaly Study Group of the Italian Society of Endocrinology. Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study. J Endocrinol Invest 2002, 25: 240-5.
6. Balkany C, Cushing GW. An association between acromegaly and thyroid carcinoma. Thyroid 1995, 5: 47-50.
7. Terzolo M, Reimondo G, Gasperi M, et al. Colonoscopic screening and follow-up in patients with acromegaly: a multicenter study in Italy. J Clin Endocrinol Metab 2005, 90: 84-90.
8. Bogazzi F, Ultimieri F, Raggi F, et al. Growth hormone inhibits apoptosis in human colonic cancer cell lines: antagonistic effects of peroxisome proliferator activated receptor-gamma ligands. Endocrinology 2004, 145: 3353-62.
9. Lincoln DT, Kaiser HE, Raju GP, Waters MJ. Growth hormone and colorectal carcinoma: localization of receptors. In Vivo 2000, 14: 41-9.
10. Jenkins P. Acromegaly and cancer. Horm Res 2004, 62 (Suppl 1): 108-15.
11. Bogazzi F, Ultimieri F, Raggi F, et al. Peroxisone proliferator activated receptor gamma expression is reduced in the colonic mucosa of acromegalic patients. J Clin Endocrinol Metab 2002, 87: 2403-6.
12. Bogazzi F, Ultimieri F, Raggi F, et al. Colonic polyps of acromegalic patients are not associated with mutations of the peroxisome proliferator activated receptor gamma gene. J Endocrinol Invest 2003, 26: 1054-8.
13. Cheung NW, Boyages SC. Increased incidence of neoplasia in females with acromegaly. Clin Endocrinol (Oxf) 1997, 47: 323-7.
14. De Menis E, Tramontin P, Conte N. Danazol and multiple hepatic adenomas: peculiar clinical findings in an acromegalic patient. Horm Metab Res 1999, 31: 476-7.
15. Colao A, Marzullo P, Ferone D, et al. Prostatic hyperplasia: an unknown feature of acromegaly. J Clin Endocrinol Metab 1998, 83: 775-9.
16. Mantero F, Terzolo M, Arnaldi G, et al. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 2000, 85: 637-44.
17. Bovio S, Cataldi A, Reimondo G, et al. Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest 2006, 29: 298-302.
18. Saeger W, Reinhard K, Reinhard C. Hyperplastic and tumorous lesions of the adrenals in an unselected autopsy series. Endocr Pathol 1998, 9: 235-9.
19. Vierhapper H, Heinze G, Gessl A, Exner M. Adrenocortical tumors: prevalence of impaired glucose tolerance and of "Paradoxical Rise" of cortisol during an oral glucose tolerance test. Exp Clin Endocrinol Diabetes 2003, 111: 415-20.
20. Tauchmanovà L, Rossi R, Biondi B, et al. Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. J Clin Endocrinol Metab 2002, 87: 4872-8.
21. Arnaldi G, Masini AM, Giacchetti G, Taccaliti A, Faloia E, Mantero F. Adrenal incidentaloma. Braz J Med Biol Res 2000, 33: 1177-89.
22. Chiodini I, Torlontano M, Scillitani A, et al. Association of subclinical hypercortisolim with type 2 diabetes mellitus: a case-control study in hopitalized patients. Eur J Endocrinol 2005, 153: 837-44.
23. Melmed S, Casanueva FF, Cavagnini F, et al; Acromegaly Treatment Consensus Workshop Participants. Guidelines for acromegaly management. J Clin Endocrinol Metab 2002, 87: 4054-8.
24. Giustina A, Barkan A, Casanueva FF, et al. Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 2000, 85: 526-9.
25. Rockall AG, Babar SA, Sohaib SA, et al. CT and MR imaging of the adrenal glands in ACTH-independent Cushing syndrome. Radiographics 2004, 24: 435-52.
26. Young WF jr. Minireview: primary aldosteronism - changing concepts in diagnosis and treatment. Endocrinology 2003, 144: 2208-13.
27. Reincke M. Subclinical Cushing's syndrome. Endocrinol Metab Clin North Am 2000, 29: 43-56.
28. Barzon L, Scaroni C, Sonino N, et al. Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates. J Clin Endocrinol Metab 1998, 83: 55-62.
29. Findling JW, Raft H. Screening and diagnosis of Cushing's syndrome. Endocrinol Metab Clin North Am 2005, 34: 385-402.
30. Baris D, Gridley G, Ron E, et al. Acromegaly and cancer risk: a cohort study in Sweden and Denmark. Cancer Causes Control 2002, 13: 395-400.
31. Mantero F, Opocher G, Armanini D, Paviotti G, Boscaro M, Muggeo M. Plasma renin activity and urinary aldosterone in acromegaly. J Endocrinol Invest 1979, 2: 13-8.
32. Strauch G, Vallotton MB, Touitou Y, Bricaire H. The renin-aldosterone system in acromegaly, follow-up report. N Engl J Med 1973, 289: 808.
33. Sleilati GG, Kovacs KT, Honasoge M. Acromegaly and pheocromocytoma: report of a rare coexistence. Endocr Pract 2002, 8: 54-60.
34. Nasushita R, Watanobe H, Goto T, et al. A case of acromegaly accompanied by adrenal preclinical Cushing's syndrome. Endocr J 1999, 46: 133-7.
35. Melmed S. Acromegaly and Cancer: not a problem? J Clin Endocrinol Metab 2001, 86: 2929-34.
36. Bogazzi F, Cosci C, Sardella C, et al. Identification of acromegalic patients at risk of developing colonic adenomas. J Clin Endocrinol Metab 2006, 31: 1351-6.
37. Grumbach MM, Biller BM, Braunstein GD, et al. Management of the clinically inapparent adrenal mass ("incidentaloma"). Ann Intern Med 2003, 138: 424-9.
38. Fottner Ch, Hoeflich A, Wolf E, Weber MM. Role of the insulin-like growth factor system in adrenocortical growth control and carcinogenesis. Horm Metab Res 2004, 36: 397-405.
39. Reincke M, Allolio B. Molecular biology of incidentally diagnosed adrenal gland space-occupying lesion. Zentralbl Chir 1997, 122: 430-7.
40. Reincke M, Fassnacht M, Väth S, Mora P, Allolio B. Adrenal incidentalomas: a manifestation of the metabolic syndrome? Endocr Res 1996, 22: 757-61.
41. Berthe E, Henry-Amar M, Michels JJ, et al. Risk of second primary cancer following differentiated thyroid cancer. Eur J Nucl Med and Mol Imaging 2004, 31: 685-91.
42. Barzon L, Scaroni C, Sonino N, Fallo F, Paoletta A, Boscaro M. Risk factors and long-term follow-up of adrenal incidentalomas. J Clin Endocrinol Metab 1998, 84: 520-6.